ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
C4 Therapeutics Inc

C4 Therapeutics Inc (CCCC)

3.805
0.305
( 8.71% )
Updated: 10:12:01

Income Statement

Balance Sheet

Cash Flow

Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 6.75M2.85M3.76M6.42M3.26M3.04M12.01M15.36M
Operating Income -32.49M-38.29M-36.23M-73.8M-37.43M-32.22M-21.44M-28.24M
Pre Tax Income -31.96M-37.19M-34.78M-70.7M-34.48M-28.36M-17.72M-24.67M
Net Income -31.96M-37.19M-34.78M-70.7M-34.75M-28.36M-17.72M-24.67M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -32.49M-38.29M-36.23M-73.8M-37.43M-32.22M-21.44M-28.24M
EBITDA -32.07M-37.77M-35.68M-72.79M-37M-31.77M-20.99M-27.8M
Year End December 30 2023 201820192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 19.36M21.38M33.2M45.79M31.1M20.76M
Operating Income -16.39M-35.45M-60.45M-82.13M-129.53M-139.03M
Pre Tax Income -15.71M-33.3M-66.96M-83.89M-128.18M-131.21M
Net Income -24.11M-42.57M-66.34M-83.89M-128.18M-132.49M
Preferred Dividends -8.4M-8.47M0000
Basic Earnings Per Share (EPS) -18.004-29.83-1.538-1.723-2.618-2.689
EBIT -16.4M-35.13M-60.45M-82.13M-129.53M-139.03M
EBITDA -15.12M-33.86M-58.83M-80.64M-127.86M-137.15M

Your Recent History

Delayed Upgrade Clock